Atea Pharmaceuticals logo
Atea Pharmaceuticals AVIR
$ 3.29 5.11%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Atea Pharmaceuticals Cash Flow 2011-2024 | AVIR

Annual Cash Flow Atea Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Operating Cash Flow

-85.4 M -121 M -87 M 297 M -12.8 M -7.91 M - - - - - - -

Depreciation & Amortization

416 K 260 K 29 K 19 K 17 K 17 K - - - - - - -

Accounts Payables

4.25 M 2.55 M 4.53 M 60 K - - - - - - - - -

Accounts Receivables

- - - - - - - - - - - - -

Total Inventories

- - - - - - - - - - - - -

All numbers in USD currency

Quarterly Cash Flow Atea Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Operating Cash Flow

- - -39.9 M - - - -29.8 M - -99.4 M -78.2 M -59 M - -11.6 M -34.2 M -16.8 M - -21.8 M -12.3 M -4.51 M - -8.89 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Depreciation & Amortization

- - 104 K - - - 104 K - 156 K 50 K 7 K - 22 K 15 K 7 K - 5 K 8 K 4 K - 4 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Accounts Payables

5.78 M 5.47 M 21.1 M 4.25 M 395 K 3.96 M 700 K 2.55 M 1.12 M 13.9 M 3.66 M 4.53 M 22.2 M 10.7 M 3.79 M 60 K 60 K 60 K 60 K 548 K 548 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Accounts Receivables

- - - - - - - - 4.51 M - - - - 50 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Inventories

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency